Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
about
Evaluation of MCT1, MCT4 and CD147 Genes in Peripheral Blood Cells of Breast Cancer Patients and Their Potential Use as Diagnostic and Prognostic Markers.Elevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer.CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer.Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study.Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial.CD147-mediated chemotaxis of CD4+CD161+ T cells may contribute to local inflammation in rheumatoid arthritis.The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors.Evaluation of Monocarboxylate Transporter 4 in Inflammatory Bowel Disease and Its Potential Use as a Diagnostic Marker.Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer
P2860
Q33624177-DBB69C46-D604-4DCF-ABD4-1E17FAA58C39Q33914079-551683A4-1486-41CD-ACC6-4D25B1C613E1Q38949683-A308F742-72D9-44BA-9BCA-CC62032606A8Q41615191-93D029F4-D07D-4879-96DF-2A1D3F25B18FQ41914358-24A0C370-42EE-490A-9120-18B54798E5EEQ47100203-02C3162E-CB86-422B-A26B-E51C4147E654Q47101394-C34AEA87-8A4F-4C44-AA45-033C4F0F850BQ47285805-AA17A289-60F7-489D-8ED5-B61B337A1A10Q48254107-5E1EA0F7-CC72-4C81-9440-3EB11EC5CC20Q49835053-CD3C598A-A25D-4D6E-B908-F9F8FA19B7BEQ55046277-B0CB6C80-4FAD-4CC1-AECD-C56719A4997EQ55374174-D1120F5F-A7EF-47BC-ACC3-19B7EF376667Q58698489-037B55E4-5618-40DB-ADD0-8D8412599CA6
P2860
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@ast
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@en
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@nl
type
label
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@ast
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@en
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@nl
prefLabel
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@ast
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@en
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@nl
P2093
P2860
P921
P3181
P356
P1476
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
@en
P2093
Adam Luginbuhl
Cory D Bovenzi
David M Cognetti
James Hamilton
Jennifer Johnson
Madalina Tuluc
Patrick Tassone
Tingting Zhan
Voichita Bar-Ad
William M Keane
P2860
P304
P3181
P356
10.1155/2015/242437
P407
P5008
P577
2015-12-08T00:00:00Z